LOM612 is used to effectively induce nuclear translocation of FOXO transcription factors (including endogenous FOXO3a and FOXO1) in a CRM-1-independent manner; upregulate expression of FOXO target genes such as p27 and FasL; and exhibit cytotoxicity against HepG2 cancer cells (IC50 = 0.64 μM) while showing minimal toxicity toward non-cancerous THLE2 cells (IC50 = 2.76 μM).